Incidence of Hortaea werneckii in a tertiary care centre in Maharashtra
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241555Keywords:
Dermatomycosis, Hortaea werneckii, Melanized fungus, Tinea nigraAbstract
Background: Hortaea werneckii, a melanized yeast-like fungus is the cause of Tinea nigra, a superficial dermatomycosis. The lesions are differential diagnosis of melanocytic lesions. Tinea nigra mainly affects people in the temperate or subtropical climates with well-demarcated, expanding, hyperchromic plaques on the palms or soles.
Methods: Skin scrapings from various lesions with suspected fungal aetiology were received after clinical assessment and were subjected to laboratory procedures, including direct KOH (10%) analysis, culture on Sabouraud dextrose agar (SDA), and incubation at 25°C and 37°C for 28 days which was further confirmed by lactophenol cotton blue preparation and slide culture.
Results: Out of 295 samples examined, a total number of 15 samples were positive for Hortaea werneckii in the time period of 1st January 2023 to 31st December 2023. 7 patients had lesions on both palmar as well as plantar region (46.66%), 3 on palmar and plantar region each (20%), 1 (6.66%) on scalp and 1 (6.66%) on face and scalp. The skin scrapings were taken and examined in 10% KOH wet mount which showed positivity of 11 (73.33%) samples. The primary isolation of the fungus was done on SDA.
Conclusions: Hortaea werneckii is the most common cause of Tinea nigra. Pigmented patches of Tinea nigra may be confused with other inflammatory or neoplastic aetiology. For Tinea nigra, skin scrapings are sufficient for diagnosis by KOH mount and culture on SDA. Generally, the lesions resolve within 2 weeks of adequate treatment. To conclude, a high suspicion should be maintained to timely diagnose the disease, avoid unnecessary invasive investigation and early administration of treatment.
Metrics
References
Ray A, Aayilliath K A, Banerjee S, Chakrabarti A, Denning DW. Burden of Serious Fungal Infections in India. Open Forum Infect Dis. 2022;9(12):ofac603.
Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.
Haldar N, Haldar N, Sharma MK, Dutta G, Haldar NR. Epidemiology of dermatomycosis in the Sub-Himalayan region of West Bengal, India. JEMDS. 2015;4(91):15619-23.
Bonifaz A, Badali H, de Hoog GS, Cruz M, Araiza J, Cruz MA, et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol. 2008;61:77-82.
Ibraheim MK, McNally MA, Tschen J. Interdigital Tinea Nigra. Cureus. 2020;12(4):e7579.
Severo LC, Bassanesi MC, Londero AT. Tinea nigra: report of four cases observed in Rio Grande do Sul (Brazil) and a review of Brazilian literature. Mycopathol. 1994;126(3):157-62.
de Hoog GS, Gerrits van den Ende AH. Nutritional pattern and eco-physiology of Hortaea werneckii, agent of human tinea nigra. Antonie Van Leeuwenhoek. 1992;62(4):321-9.
Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin. 2003;21(3):395-400.
Falcão EM, Trope BM, Martins NR, Barreiros Mda G, Ramos-E-Silva M. Bilateral tinea nigra plantaris with good response to isoconazole cream: a case report. Case Rep Dermatol. 2015;7(3):306-10.
Aroeira Neves J, Costa OG. Tinea nigra. Arch Derm Syphilol. 1947;55(1):67-84.
Criado PR, Delgado L, Pereira GA. Dermoscopy revealing a case of Tinea Nigra. An Bras Dermatol. 2013;88(1):128-9.
Uijthof JM, de Cock AW, de Hoog GS, Quint WG, van Belkum A. Polymerase chain reaction-mediated genotyping of Hortaea werneckii, causative agent of tinea nigra. Mycoses. 1994;37(9-10):307-12.
Perez C, Colella MT, Olaizola C, Hartung de Capriles C, Magaldi S, et al. Tinea nigra: report of twelve cases in Venezuela. Mycopathol. 2005;160(3):235-8.
Sayegh-Carreño R, Abramovits-Ackerman W, Girón GP. Therapy of tinea nigra plantaris. Int J Dermatol. 1989;28(1):46-8.
Ng KP, Soo-Hoo TS, Na SL, Tay ST, Hamimah H, Lim PC, et al. The mycological and molecular study of Hortaea werneckii isolated from blood and splenic abscess. Mycopathol. 2005;159:495-500.
Pathave H, Dash M, Sarangi G, Mohanty P, Bisoyi D. Clinicomycological study of superficial mycoses: a changing trend of increasing non-dermatophyte mold infection. J Coll Medi Sciences-Nepal. 2022;18(1):49-59.
Sarangi G, Dash D, Chayani N, Patjoshi SK, Jena S. Bilateral Tinea Nigra of palm: a rare case report from Eastern India. Ind J Med Microbiol. 2014;32(1):86-8.
Uezato H, Gushi M, Hagiwara K, Kayo S, Hosokawa A, Nonaka S. A case of tinea nigra palmaris in Okinawa, Japan. J Dermatol. 2006;33(1):23-9.
Cabrera R, Sabatin N, Urrutia M, Sepúlveda R. Tiña negra (tinea nigra): comunicación de un caso alóctono en Chile [Tinea nigra: a allochthonous case report in Chile]. Rev Chilena Infectol. 2013;30(1):90-3.
Pegas JR, Criado PR, Lucena SK, de Oliveira MA. Tinea nigra: report of two cases in infants. Pediatr Dermatol. 2003;20(4):315-7.
Tseng SS, Whittier S, Miller SR, Zalar GL. Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma. Cutis. 1999;64(4):265-8.
Prasanna S, Jada SK. Karthika by. Hortaea werneckii and Rhodotorula rubra. Int J Curr Res. 2016;8(10):39922-4.
Kelarestaghi A, Hashemi SJ, Rafat Z, Kelarestaghi H, Moqaddam ZR, Maboudi A, et al. The first report of tinea nigra from Iran. New Microbes New Infect. 2022;49-50:101032.
Hughes JR, Moore MK, Pembroke AC. Tinea nigra palmaris. Clin Experim Dermatol. 1993;18(5):481-2.